Neuroscience R&D reasearching mechanism-first platform developments across neural recovery biology, scaffold innovation, and neuroresilience pathways.

NeuroReset™ Neural recovery biology platform exploring measurable circuit-state stabilization after prolonged dysregulation.

Neurophorol™ Cannabinoid-inspired scaffold innovation (xanthene direction) designed for systematic profiling and endpoint mapping.

Mycophorol™ Fungal-inspired neuroresilience platform designed for biomarker and metabolomics-driven evaluation.

Precision Peptide Therapeutics

NeuroRelief-P™ | NeuroRegen-P™ | NeuroReset-P™

Patent Pending – PATP1280.03 © Biotech International Institute —

Bill Carrington & Dominic Carrington

NeuroRelief-P™ Peptide innovation for pain modulation, engineered to relieve chronic and neuropathic pain without systemic risks.

NeuroRegen-P™ Activates regenerative signaling to drive axonal growth and synaptic repair for injury and degenerative conditions.

NeuroReset-P™ Stabilizes neural circuits and supports recovery from substance dependency through structural and biochemical rebalancing.

Research-stage & investigational. No clinical or field-performance claims.